ABIOMED Inc (NASDAQ:ABMD)
| 305.62 BATS BZX Real-Time Price As of Aug 04 |  0.00 / 0.00%Today’s Change | 119.01 Today|||52-Week Range 310.97 | +79.15% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2016 | 2017 | 2018 | 2019 | |||
| Assets | Cash | 48.2M | 39.0M | 43.0M | 121.0M | |
| Short Term Investment Cash | 25.8M | -9.2M | 3.9M | 78.0M | ||
| Cash & Short Term Investments | 212.1M | 229.9M | 362.2M | 491.7M | ||
| Receivables | Receivables | 42.8M | 54.1M | 70.0M | 90.8M | |
| Inventories | Inventories | 26.7M | 34.9M | 50.2M | 80.9M | |
| Current Assets | Other Current Assets | 6.8M | 8.0M | 11.8M | 13.7M | |
| Current Assets | 288.4M | 327.0M | 494.3M | 677.2M | ||
| Total Assets | Property, Plant and Equipment - Gross | 42.3M | 107.7M | 145.0M | 184.7M | |
| Depreciation | -19.1M | -20.0M | -27.9M | -39.7M | ||
| Intangible Assets | 48.4M | 45.5M | 52.5M | 50.6M | ||
| Other Assets | 48.4M | 46.6M | 54.1M | 52.1M | ||
| Total Assets | 423.9M | 550.4M | 786.4M | 1.1B | ||
| Liabilities | Accounts Payable | 9.4M | 20.6M | 23.6M | 32.2M | |
| Short Term Debt | 0.00 | 799.0K | 0.00 | 0.00 | ||
| Accrued Expenses | 6.5M | 10.5M | 10.2M | 11.0M | ||
| Other Current Liabilities | 16.3M | 21.7M | 26.2M | 28.6M | ||
| Other Liabilities | 46.5M | 69.6M | 84.7M | 106.0M | ||
| Total Liabilities | Long Term Debt | 0.00 | 15.5M | 0.00 | 0.00 | |
| Deferred Taxes | -57.7M | -33.9M | -69.8M | -76.7M | ||
| Other Liabilities | 7.8M | 12.4M | 11.3M | 10.6M | ||
| Total Liabilities | 55.2M | 98.3M | 96.9M | 117.5M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Equity | 368.8M | 452.1M | 689.5M | 936.9M | ||
| Total Shareholder Equity | 368.8M | 452.1M | 689.5M | 936.9M | ||
| Share Information | Common Shares Outstanding | 42.6M | 43.7M | 44.4M | 45.1M | |
| Addtl. Info. | No data currently available for this section. | |||||
